COMPARISON OF COST- EFFICACY OF SUBCUTANEOUS ABATACEPT VERSUS ADALIMUMAB IN THE TREATMENT OF PATIENTS WITH RHEUMATOID ARTHRITIS

被引：0
|
作者：
Khanna, D. [1 ]
Massarotti, E. [2 ]
Rosenblatt, L. [3 ]
Budd, D. [3 ]
Sabater, J. [4 ]
Hebden, T. [3 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
[2] Brigham & Womens Hosp, Boston, MA 02115 USA
[3] Bristol Myers Squibb Co, Princeton, NJ USA
[4] Bristol Myers Squibb Int, Paris, France
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：340 / 341
页数：2
相关论文
共 50 条
  • [41] COST ANALYSIS OF RITUXIMAB VERSUS INFLIXIMAB, ADALIMUMAB, ETANERCEPT AND ABATACEPT FOR RHEUMATOID ARTHRITIS FROM THE PERSPECTIVE OF A PRIVATE PAY IN BRAZIL
    Santos, E. A.
    Saggia, M. G.
    VALUE IN HEALTH, 2009, 12 (07) : A522 - A522
  • [42] COMPARISON OF ABATACEPT EFFICACY AND SAFETY IN DIFFERENT STAGES RHEUMATOID ARTHRITIS
    Maria, K. A.
    Lukina, G. V.
    Sigidin, Y. A.
    Aronova, E. S.
    Glukhova, S. I.
    Luchihina, E. L.
    Karateev, D. E.
    Nasonov, E. L.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1051 - 1051
  • [43] Efficacy and safety of adalimumab treatment in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis
    Poddubnyy, Denis
    Rudwaleit, Martin
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (04) : 655 - 673
  • [44] Bioavailability of adalimumab following subcutaneous injections in rheumatoid arthritis patients
    Velagapudi, R
    Noertershauser, P
    Awni, W
    Granneman, R
    Kupper, H
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2005, 77 (02) : P84 - P84
  • [45] HEAD-TO-HEAD COMPARISON OF SUBCUTANEOUS ABATACEPT VERSUS ADALIMUMAB ON BACKGROUND METHOTREXATE IN RHEUMATOID ARTHRITIS: BLINDED TWO-YEAR RESULTS FROM THE AMPLE STUDY
    Weinblatt, Michael E.
    Schiff, Michael H.
    Valente, Robert
    van der Heijde, Desiree
    Citera, Gustavo
    Elegbe, Ayanbola
    Maldonado, Michael A.
    Fleischmann, Roy
    RHEUMATOLOGY, 2014, 53 : 88 - 88
  • [46] SUBCUTANEOUS ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS: A REAL-LIFE EXPERIENCE
    Sarmiento-Monroy, J. C.
    Rodriguez-Lopez, M.
    Molano-Gonzalez, N.
    Rojas-Villarraga, A.
    Mantilla, R. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 725 - 725
  • [47] A COST PER RESPONDER ANALYSIS OF ABATACEPT VERSUS ADALIMUMAB FOR THE TREATMENT OF RHEUMATOID ARTHRITIS AMONG PATIENTS WITH SHARED EPITOPE (SE) POSITIVITY FROM A UNITED STATES PAYER PERSPECTIVE
    Park, S. H.
    Han, X.
    Lobo, F.
    Nanji, S.
    Patel, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1868 - 1869
  • [48] Comparison of the clinical efficacy and safety of subcutaneous versus oral administration of methotrexate in patients with active rheumatoid arthritis
    Braun, J.
    Kaestner, P.
    Flaxenberg, P.
    Waehrisch, J.
    Hanke, P.
    Demary, W.
    von Hinueber, U.
    Rockwitz, K.
    Heitz, W.
    Pichlmeier, U.
    Guimbal-Schmolck, C.
    Brandt, A.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (01): : 73 - 81
  • [49] SUBCUTANEOUS ABATACEPT IN PATIENTS WITH RHEUMATOID ARTHRITIS: A REAL-LIFE EXPERIENCE
    Sarmiento-Monroy, J. C.
    Villota-Eraso, C.
    Mantilla-Ribero, M. J.
    Molano-Gonzalez, N.
    Rodriguez-Jimenez, M.
    Rojas-Villarraga, A.
    Mantilla, R. D.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1024 - 1024
  • [50] Comparison of the Efficacy and Safety of Abatacept in Rheumatoid Arthritis Patients with and Without Interstitial Lung Disease
    Sasaki, Sho
    Ishii, Akira
    Sugiyama, Mai
    Izumi, Yuto
    Nakagome, Yoko
    Hirano, Kazuki
    Kurabayashi, Takayoshi
    Sasaki, Noriko
    Yamada, Chiho
    Sato, Shinji
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
12345